guest ::
| Home > Publications database > Fractal Dimension of High-Risk Neuroblastoma Vascularity in MRI Is Associated with Chemotherapy Response and Event-Free Survival. |
| Home > Publications database > Fractal Dimension of High-Risk Neuroblastoma Vascularity in MRI Is Associated with Chemotherapy Response and Event-Free Survival. |
| Journal Article | DKFZ-2025-02940 |
; ; ; ; ; ; ; ; ; ;
2026
RSNA, Radiological Society of North America
Oak Brook, IL
Abstract: Purpose To assess therapeutic and prognostic implications of perfusion characterization by fractal analysis using routine MRI in high-risk primary neuroblastomas and to establish a pathophysiologic connection between vascularity phenotype, perfusion imaging characteristics, and treatment response. Materials and Methods In a retrospective cohort study across 30 centers, MRI data of patients with high-risk neuroblastoma (June 2005-February 2021) were collected at the time point of diagnosis (TP1) and after induction chemotherapy before surgery (TP2), with data split into separate discovery (single-center) and validation cohorts (29 centers). Fractal analysis was performed on contrast-enhanced, fat-saturated, T1-weighted sequences at both time points to obtain voxel-wise local fractal dimension (FD) maps for predicting volumetric tumor response. The association of global FD with event-free survival (EFS) was assessed using a Cox proportional hazards model. Additionally, FD was calculated from CD34-stained endothelium in selected histologic tumor samples. Accuracy of response prediction, prognostic value for EFS, and correlation between FD of immunohistochemical vascularity and MRI-derived perfusion were also evaluated. Results In 73 patients (median age, 3 years [IQR, 3]; 39 male patients; discovery cohort, n = 36; validation cohort, n = 37), local FD maps helped predict volumetric tumor response to induction chemotherapy between TP1 and TP2 with good accuracy (root mean squared error, 47.78 mL; R2 = 0.94; P < .001), visualizing intratumor high perfusion complexity in areas with low response potential. In multivariate Cox proportional hazards modeling, MYCN status (hazard ratio, 2.30; 95% CI: 1.16, 4.55; P = .017) and global FD at TP2 (hazard ratio, 0.65; 95% CI: 0.47, 0.88; P = .006) were significantly associated with EFS. Complexity of both CD34-immunohistochemical microvascularity (1.23 ± 0.09 [SD] to 1.44 ± 0.07, P < .001) and MRI perfusion (3.40 ± 0.04 to 3.53 ± 0.07, P < .001) increased throughout induction chemotherapy. Conclusion Fractal analysis of MRI-derived perfusion complexity was associated with spatial heterogeneity of chemotherapy response and stratified prognosis in MYCN nonamplified high-risk neuroblastoma, supporting its potential as an imaging biomarker linked to microvascular architecture. German Clinical Trial Registry: DRKS00023442 Keywords: Pediatrics, MR-Imaging, Nervous-Peripheral, Fractal Analysis, Tissue Characterization, Tumor Response Supplemental material is available for this article. © RSNA, 2025.
Keyword(s): Humans (MeSH) ; Neuroblastoma: drug therapy (MeSH) ; Neuroblastoma: diagnostic imaging (MeSH) ; Neuroblastoma: blood supply (MeSH) ; Neuroblastoma: pathology (MeSH) ; Male (MeSH) ; Female (MeSH) ; Magnetic Resonance Imaging: methods (MeSH) ; Fractals (MeSH) ; Retrospective Studies (MeSH) ; Child, Preschool (MeSH) ; Child (MeSH) ; Infant (MeSH) ; Prognosis (MeSH) ; Induction Chemotherapy (MeSH) ; Disease-Free Survival (MeSH) ; Neovascularization, Pathologic: diagnostic imaging (MeSH) ; Fractal Analysis ; MR-Imaging ; Nervous-Peripheral ; Pediatrics ; Tissue Characterization ; Tumor Response
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Emerging Sources Citation Index ; IF < 5 ; JCR ; SCOPUS ; Web of Science Core Collection
|
The record appears in these collections: |
